Correlation Between Inozyme Pharma and IVERIC Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and IVERIC Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and IVERIC Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and IVERIC Bio, you can compare the effects of market volatilities on Inozyme Pharma and IVERIC Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of IVERIC Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and IVERIC Bio.

Diversification Opportunities for Inozyme Pharma and IVERIC Bio

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Inozyme and IVERIC is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and IVERIC Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IVERIC Bio and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with IVERIC Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IVERIC Bio has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and IVERIC Bio go up and down completely randomly.

Pair Corralation between Inozyme Pharma and IVERIC Bio

Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the IVERIC Bio. In addition to that, Inozyme Pharma is 5.06 times more volatile than IVERIC Bio. It trades about -0.03 of its total potential returns per unit of risk. IVERIC Bio is currently generating about 0.28 per unit of volatility. If you would invest  3,808  in IVERIC Bio on September 4, 2024 and sell it today you would earn a total of  187.00  from holding IVERIC Bio or generate 4.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy5.63%
ValuesDaily Returns

Inozyme Pharma  vs.  IVERIC Bio

 Performance 
       Timeline  
Inozyme Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inozyme Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
IVERIC Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days IVERIC Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, IVERIC Bio is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Inozyme Pharma and IVERIC Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inozyme Pharma and IVERIC Bio

The main advantage of trading using opposite Inozyme Pharma and IVERIC Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, IVERIC Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IVERIC Bio will offset losses from the drop in IVERIC Bio's long position.
The idea behind Inozyme Pharma and IVERIC Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges